scispace - formally typeset
J

Javier Narváez

Researcher at Bellvitge University Hospital

Publications -  254
Citations -  5652

Javier Narváez is an academic researcher from Bellvitge University Hospital. The author has contributed to research in topics: Rheumatoid arthritis & Giant cell arteritis. The author has an hindex of 39, co-authored 234 publications receiving 4616 citations. Previous affiliations of Javier Narváez include University of Barcelona & University Hospital Complex Of Vigo.

Papers
More filters
Journal ArticleDOI

Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis.

TL;DR: In patients that developed GCA on a background of a prior history of polymyalgia rheumatica, a late TAB is also generally informative despite long-term treatment with low doses of corticosteroids.
Journal ArticleDOI

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.

F. David Carmona, +72 more
TL;DR: This study provides evidence of a strong contribution of HLA class I and II molecules to susceptibility to GCA, and confirmed a key role for the functional PTPN22 rs2476601 variant and proposed other putative risk loci involved in Th1, Th17, and Treg cell function.
Journal ArticleDOI

MR imaging of synovial tumors and tumor-like lesions.

TL;DR: The goal is to review the MR features of pigmented villonodular synovitis, giant-cell tumor of the tendon sheath, synovial chondromatosis,synovial hemangioma, lipoma arborescens, Synovial cysts and synovials sarcoma, emphasizing those findings that suggest a specific diagnosis.
Journal ArticleDOI

Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis

TL;DR: MRI may be a useful technique for diagnosing patients with occult major artery involvement in GCA, whether presenting with classic symptoms of temporal arteritis or PMR, and its utility for monitoring the course of the disease and response to treatment requires further confirmation.